| 2015-NAUM-67042 | |
| Currently, medical operations that require an orthopedic implant must be followed-up with a second surgery to remove the implant or the accompanying hardware of the implant. The additional surgery results in higher medical costs for patients and increases the risk of complications. However, the use of nontoxic, biodegradable implants could eliminate the need for a second surgery. According to BCC Research (2015), the global market for implantable biomaterials is expected to grow through 2019 at a compounded annual growth rate of 6.7 percent. Researchers at Purdue University have developed technology for a resorbable orthopedic implant that is safely absorbed after providing adequate support for damaged bones. This resorbable metal technology provides superior properties over its counterparts, including high porosity for vascular invasion, control of particulate size and degradation rate, and control of mechanical properties to support fixation. Furthermore, the inclusion of hydroxyapatite particulates helps promote bone cell mineralization. Advantages: -Eliminates the need for a second surgery to remove implant -Superior control over porosity, surface area and roughness, and corrosion rates -Promotes bone recovery with the inclusion of hydroxyapatite particulates Potential Applications: -Medical/Health -Orthopedic injuries Related Publications: Michael Heiden, Eric Nauman, Lia Stanciu. Bioresorbable Fe–Mn and Fe–Mn–HA Materials for Orthopedic Implantation: Enhancing Degradation through Porosity Control. Advanced Healthcare Materials 2017. DOI: 10.1002/adhm.201700120 |
|
|
|
|
Jul 18, 2016
Utility Patent
United States
10,898,331
Jan 26, 2021
Jan 25, 2021
DIV-Patent
United States
(None)
(None)
Jul 17, 2015
Provisional-Patent
United States
(None)
(None)
|
|
|
Purdue Office of Technology Commercialization The Convergence Center 101 Foundry Drive, Suite 2500 West Lafayette, IN 47906 Phone: (765) 588-3475 Fax: (765) 463-3486 Email: otcip@prf.org |